X4 Pharmaceuticals Grants 32,000-Share Options at $4.13 Exercise Price
X4 Pharmaceuticals granted inducement awards of options for 32,000 shares effective March 31, 2026 under its 2019 Inducement Plan in compliance with Nasdaq Rule 5635(c)(4). The options carry a ten-year term, $4.13 exercise price and vest 25% after 12 months and monthly over the next 36 months.
1. Inducement Awards Details
Effective March 31, 2026, X4 Pharmaceuticals issued options for an aggregate of 32,000 shares under its 2019 Inducement Equity Incentive Plan as material inducements for new employees, approved by the Compensation Committee pursuant to Nasdaq Listing Rule 5635(c)(4).
2. Option Terms and Vesting Schedule
Each option carries a ten-year term and an exercise price of $4.13 per share, equal to the March 31 closing price; vesting is structured with 25% after 12 months and the remaining 75% vesting in equal monthly installments over 36 additional months, subject to continued employment.
3. Plan Purpose and Compliance
The 2019 Inducement Equity Incentive Plan is reserved for equity awards to individuals not previously employed by X4 Pharmaceuticals, ensuring compliance with Nasdaq requirements for inducement grants and aligning new hires with company performance goals.